Navigation Links
Demand for DrugDev Spark™ Soars Among Small Biotechs and Pharma Seeking Best-in-Class Technology for Clinical Trial Planning, Startup and Conduct
Date:9/12/2017

DrugDev, a QuintilesIMS company, continues to strengthen its position as the clinical technology provider for small to mid-size biotechs and pharma worldwide with continued adoption of the DrugDev Spark™ unified clinical trial suite.

Sponsors unfamiliar with DrugDev Spark can experience solutions for site selection and activation, eConsent, site payments and site engagement with hands-on technology demonstrations and best practice discussions at a series of educational “Clinical Coffee” events. Register here to attend the live session scheduled for September 27 from 9am-12pm ET in Parsippany, New Jersey.

DrugDev’s growth has come as a result of proven success improving clinical trials across therapeutic areas with sponsors of all sizes in addition to Top 20 global pharmaceutical clients.

Watch a rare disease webinar with Alnylam and AMO Pharma discussing how to use technology to design and conduct more efficient and effective clinical research.

“Clinical innovation isn’t reserved exclusively for Top 20 Pharma trying to build their brand as a sponsor of choice,” said DrugDev Chief Commercial Officer Brett Kleger. “Increasingly, smaller pharmas and biotechs are adopting DrugDev Spark to improve site relationships and productivity, elevate their CRO, and support internal study teams with efficient automation tools. Scalable technology like ours is flexible enough for any budget, and levels the playing field for smaller sponsors and biotechs worldwide.”

To learn how DrugDev Spark is changing the game for smaller pharmaceutical companies, begin a conversation or request a demo at http://www.drugdev.com.

About DrugDev
DrugDev, a QuintilesIMS company, helps the world do more trials through industry-wide collaboration, standardization and a beautiful technology experience. DrugDev Spark™, the unified clinical operations suite, is comprised of proven solutions used by 85 sponsors and CROs on nearly 2,000 clinical trials to transform the quality and efficiency of clinical trials from startup through closeout. DrugDev Spark is powered by the DrugDev Golden Number, the award-winning universal identifier for global site facilities and investigators used by TransCelerate and the Investigator Databank. Learn why 9 of the top 10 sponsors and 4 of the top 5 CROs trust DrugDev by scheduling a demo of DrugDev Spark at drugdev.com.

Read the full story at http://www.prweb.com/releases/2017/09/prweb14677792.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. AMRI’s Global Analytical Services Introduces Comprehensive Forced Degradation Services To Meet Pharmaceutical Industry Demand
2. Franz's Allegro Common Lisp Meets Demand for High Performance Artificial Intelligence and IoT Applications
3. Cannabis Companies Continue to Invest in Infrastructure and Grow Facilities to Keep up With Rising Demand
4. Nanobiotechnology - Global Strategic Business Report 2015-2022 - Demand for Novel Products to Push Up Growth - Research and Markets
5. SSCI Expands Biochemistry Services to Meet Growing Industry Demand
6. CohBar Inc. Presentation Now Available for On-Demand Viewing
7. SpineFrontier Enhances the MISquito Percutaneous Pedicle Screw System in Response to Growing Demand
8. Continuous Flow Chemistry Methods Revealed in On-Demand Webinars from METTLER TOLEDO
9. Demand of Amyloglucosidase Market to 2020 Analysed with Sales, Manufacture Share and Type
10. Chi-Med webcast presentation now available for on-demand viewing: Deutsche Bank ADR Virtual Investor Conference
11. Global Biomaterials Market - By Type, Application, Regions - Market Size, Demand Forecasts, Industry Trends and Updates (2014- 2020)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2019)... YORK and SOMERSET, N.J. (PRWEB) , ... June ... ... Catalent Biologics, today announced that they have entered into an agreement for production ... product candidates, IC-100 for the treatment of rhodopsin-mediated autosomal dominant retinitis pigmentosa (RHO-adRP) ...
(Date:6/12/2019)... EGG HARBOR TOWNSHIP, N.J. (PRWEB) , ... June ... ... premier manufacturer of custom built, helium-based leak testing instruments for the Pharmaceutical, Biotechnology, ... partnership agreement with Shanghai Zillion has been signed. The agreement will grant exclusive ...
(Date:6/11/2019)... ... June 10, 2019 , ... ... in an upcoming episode, scheduled to broadcast 4Q/2019. Check your local listings for ... will educate viewers about how its technology facilitates laboratories to improve efficiency and ...
(Date:6/11/2019)... ... June 11, 2019 , ... Mytonomy, the ... national leader in opioid treatment, announced today they are partnering to combat the ... recently deployed its virtual care platform at the Mayo Clinic to drive shared ...
Breaking Biology Technology:
(Date:8/6/2019)... ... ... Keck Graduate Institute (KGI) President Sheldon Schuster has announced Martin Zdanowicz as the ... is highly regarded as an innovative leader who prioritizes student success and faculty development,” ... build on the success of the KGI School of Pharmacy and Health Sciences.” , ...
(Date:8/1/2019)... ... August 01, 2019 , ... The GENSPEED platform is a compact, fast and ... fully developed with over 100 units deployed in the field for multiple applications. ... collaboration with axiVEND will give us a foothold in the USA to better support ...
(Date:8/1/2019)... ... 2019 , ... USDM Life Sciences (USDM) announces that Jay Crowley, Vice President ... addressing challenges with the upcoming EU MDR IVDR regulations . , ... variety of positions over his 26 years at the FDA, including developing the framework ...
Breaking Biology News(10 mins):